new indications for glp 1 drugs GLP-1-based therapies diabetes, obesity and beyond GLP-1 Drugs: Where We Are
Description
The SURMOUNT-5 trial changed that
Regul Pept 2010
7 Why real-world GLP-1 results differ from clinical trials Clinical trials enrol carefully selected participants, provide intensive coaching and deliver high medication doses
GLP-1 therapy has also shown benefit in improving atherothrombosis markers (e.g., inflammation, endothelial dysfunction, clotting in this population)
Relationship between diet, exercise, and pharmacotherapy to enhance the GLP-1 levels in type 2 diabetes
In addition, 2.0 M Compound K (CK), a metabolite of ginsenoside produced by intestinal flora, increases the expression of Gcg and GLP-1 secretion and promotes L-cell differentiation under high-glucose conditions (50 mM) in NCI-H716 cells
